Intech Biopharm Corporation (6461)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
28. 90
+0.9
+3.2143%
NT$
- Market Cap
- P/E Ratio
- Div Yield
144,836 Volume
- Eps
NT$ 28
Previous Close Want to track 6461 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intech Biopharm Corporation (6461) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.45B
Trailing P/E (ttm) -6.47
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) 66.29
Price/Book (mrq) 3.5
Enterprise Value/Revenue 91.69
Enterprise Value/EBITDA -12.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 264.45K
Average volume (90 days) 155.76K
Price summary
52-Week low 22.79
52-Week high 42.44
Beta -
50-Day moving average 24.09
200-Day moving average 18.34
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 309:500
Last split Date 2 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.93%
Operating margin -9.58%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.36
Total debt (mrq) -
Total Debt/Equity (mrq) 1.49
Current ratio (mrq) 1.62%
Book value per share (mrq) 8.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
